TF
GSK icon

Tompkins Financial’s GSK GSK Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$3.84K Hold
100
﹤0.01% 482
2025
Q1
$3.87K Hold
100
﹤0.01% 498
2024
Q4
$3.38K Sell
100
-1,040
-91% -$35.2K ﹤0.01% 479
2024
Q3
$46.6K Hold
1,140
﹤0.01% 347
2024
Q2
$43.9K Hold
1,140
﹤0.01% 357
2024
Q1
$48.9K Hold
1,140
0.01% 352
2023
Q4
$42.2K Hold
1,140
0.01% 357
2023
Q3
$41.3K Sell
1,140
-1,884
-62% -$68.3K 0.01% 334
2023
Q2
$108K Hold
3,024
0.02% 250
2023
Q1
$108K Hold
3,024
0.02% 250
2022
Q4
$107K Buy
+3,024
New +$107K 0.02% 249
2022
Q3
Sell
-3,955
Closed -$172K 600
2022
Q2
$172K Hold
3,955
0.03% 196
2022
Q1
$173K Buy
3,955
+2,355
+147% +$103K 0.02% 212
2021
Q4
$71K Hold
1,600
0.01% 200
2021
Q3
$61K Buy
+1,600
New +$61K 0.01% 212
2021
Q1
$57K Hold
1,600
0.01% 243
2020
Q4
$59K Sell
1,600
-300
-16% -$11.1K 0.01% 223
2020
Q3
$71K Hold
1,900
0.01% 208
2020
Q2
$78K Sell
1,900
-100
-5% -$4.11K 0.02% 198
2020
Q1
$76K Buy
2,000
+300
+18% +$11.4K 0.02% 200
2019
Q4
$80K Buy
1,700
+1,300
+325% +$61.2K 0.01% 221
2019
Q3
$17K Sell
400
-322
-45% -$13.7K ﹤0.01% 300
2019
Q2
$29K Hold
722
0.01% 274
2019
Q1
$30K Buy
722
+100
+16% +$4.16K 0.01% 275
2018
Q4
$24K Hold
622
0.01% 287
2018
Q3
$25K Hold
622
0.01% 306
2018
Q2
$25K Buy
+622
New +$25K 0.01% 320
2017
Q3
Sell
-450
Closed -$19K 418
2017
Q2
$19K Buy
450
+300
+200% +$12.7K ﹤0.01% 283
2017
Q1
$6K Sell
150
-150
-50% -$6K ﹤0.01% 327
2016
Q4
$12K Hold
300
﹤0.01% 308
2016
Q3
$13K Hold
300
﹤0.01% 308
2016
Q2
$13K Hold
300
﹤0.01% 369
2016
Q1
$12K Sell
300
-300
-50% -$12K ﹤0.01% 364
2015
Q4
$24K Hold
600
0.01% 351
2015
Q3
$23K Hold
600
0.01% 359
2015
Q2
$25K Sell
600
-1,467
-71% -$61.1K 0.01% 355
2015
Q1
$95K Buy
2,067
+500
+32% +$23K 0.02% 211
2014
Q4
$67K Sell
1,567
-240
-13% -$10.3K 0.02% 236
2014
Q3
$83K Sell
1,807
-998
-36% -$45.8K 0.02% 206
2014
Q2
$150K Hold
2,805
0.04% 176
2014
Q1
$149K Hold
2,805
0.04% 175
2013
Q4
$149K Buy
2,805
+196
+8% +$10.4K 0.04% 170
2013
Q3
$131K Buy
2,609
+1,309
+101% +$65.7K 0.04% 170
2013
Q2
$65K Buy
+1,300
New +$65K 0.02% 206